drugset / Trial / NCT03735030

Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation

NCT03735030

Phase 1 Completed 26 enrolled IBSA Institut Biochimique SA
RandomizedCrossoverOpen-labelTreatment

Summary

In the present study, the rate and extent of hCG absorption will be compared between the two treatments in healthy women aged 20 to 45 years.

Timeline

Start
2018-11-27
Primary completion
2019-08-02
Completion
2019-08-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ovidrel Protein / enzyme biologic 6500 iu Subcutaneous
Subject human chorionic gonadotropin Protein / enzyme biologic 10000 iu Subcutaneous

Indications